EPISODE · Feb 13, 2023 · 1H 13M
"A" is for Avidity
from MyFSHD · host Peter L Jones, PhD
"Why, sometimes I've believed as many as six impossible things before breakfast." Experimental therapies designed specifically for FSHD are finally arriving for trial in the clinic (i.e., in people). Today we discuss the upcoming Phase 1/2 clinical trial from Avidity using their antibody oligo conjugated siRNA designed specifically to knockdown the DUX4 mRNA in FSHD.
NOW PLAYING
"A" is for Avidity
0:00
1:13:58
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
URL copied to clipboard!